Riley DR, Essa H, Austin P, Preston F, et al. All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes. Diabetes Obes Metab 2023 Jun 29. doi: 10.1111/dom.15185.
PMID: 37385958